XML 111 R51.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Summary of significant accounting policies - Additional Information (Detail) (USD $) | 3 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended
--- | --- | --- | --- | ---
Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2011 | Sep. 30, 2011 | Jun. 30, 2011 | Mar. 31, 2011 | Dec. 31, 2012 Unit | Dec. 31, 2011 | Dec. 31, 2010 | Dec. 31, 2012 Musculoskeletal Transplant Foundation ("MTF") [Member] | Dec. 31, 2012 Customers and distributors based in Europe [Member] | Jan. 31, 2012 Collaborative Arrangement [Member] Musculoskeletal Transplant Foundation ("MTF") [Member] Y | Dec. 31, 2012 Collaborative Arrangement [Member] Musculoskeletal Transplant Foundation ("MTF") [Member] | Dec. 31, 2011 Collaborative Arrangement [Member] Musculoskeletal Transplant Foundation ("MTF") [Member] | Dec. 31, 2010 Collaborative Arrangement [Member] Musculoskeletal Transplant Foundation ("MTF") [Member] | Dec. 31, 2009 Collaborative Arrangement [Member] Musculoskeletal Transplant Foundation ("MTF") [Member] Y | Dec. 31, 2012 Developed Technology [Member]
Foreign Currency Translation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Transactional foreign currency gains and (losses), including those generated from intercompany operations |  |  |  |  |  |  |  |  | $ 500,000 | $ 1,600,000 | $ 700,000 |  |  |  |  |  |  |  |
Weighted average amortization period ( in years) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 11 years
Number of reporting units |  |  |  |  |  |  |  |  | 2 |  |  |  |  |  |  |  |  |  |
Period of agreement with MTF (in years) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10 |
Extended Period of existing agreement with MTF (in years) |  |  |  |  |  |  |  |  |  |  |  |  |  | 15 |  |  |  |  |
Marketing fee |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 46,500,000 | 37,100,000 | 29,800,000 |  |
Advertising expense |  |  |  |  |  |  |  |  | 200,000 | 300,000 | 500,000 |  |  |  |  |  |  |  |
Expenditures for research and development |  |  |  |  |  |  |  |  | 28,577,000 | 22,861,000 | 27,958,000 | 3,000,000 |  |  |  |  |  |  |
Net Sales | $ 112,035,000 | $ 114,752,000 | $ 119,492,000 | $ 116,041,000 | $ 123,085,000 | $ 117,306,000 | $ 116,670,000 | $ 113,060,000 | $ 462,320,000 | $ 470,121,000 | $ 460,629,000 |  | $ 55,000,000 |  |  |  |  |  |

X
- Definition Represents the extended period of the existing agreement with Musculoskeletal Transplant Foundation ("MFT"). + References No definition available. + Details
Name: | ofix_ExtendedPeriodOfAgreement
Namespace Prefix: | ofix_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Foreign Currency Exchange Gain Loss + References No definition available. + Details
Name: | ofix_ForeignCurrencyExchangeGainLoss
Namespace Prefix: | ofix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ofix_ForeignCurrencyTranslationLineItems
Namespace Prefix: | ofix_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of reporting units of the entity, which is consistent with the entity's reporting segments. + References No definition available. + Details
Name: | ofix_NumberOfReportingUnits
Namespace Prefix: | ofix_
Data Type: | xbrli:positiveIntegerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the period of the agreement with Musculoskeletal Transplant Foundation ("MFT"). + References No definition available. + Details
Name: | ofix_PeriodOfAgreement
Namespace Prefix: | ofix_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 720 -SubTopic 35 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 93-7 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. + Details
Name: | us-gaap_AdvertisingExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 + Details
Name: | us-gaap_MarketingExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141 -Paragraph 51 -Subparagraph g -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 86 -Paragraph 11, 12 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 985 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 2 -Paragraph 12, 13 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_SalesRevenueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration